Bloomberg Anywhere Login

Bloomberg

Connecting decision makers to a dynamic network of information, people and ideas, Bloomberg quickly and accurately delivers business and financial information, news and insight around the world.

Company

Financial Products

Enterprise Products

Media

Customer Support

  • Americas

    +1 212 318 2000

  • Europe, Middle East, & Africa

    +44 20 7330 7500

  • Asia Pacific

    +65 6212 1000

Communications

Industry Products

Media Services

Follow Us


Last 2,277 GBp
Change Today +34.00 / 1.52%
Volume 464.6K
HIK On Other Exchanges
Symbol
Exchange
London
OTC US
OTC US
Frankfurt
As of 11:35 AM 08/27/15 All times are local (Market data is delayed by at least 15 minutes).
text size: T | T
Back to Snapshot
Company Description

Contact Info

13 Hanover Square

London, W1S 1HW

United Kingdom

Phone: 44 20 7399 2760

Fax: 44 20 7399 2761

Hikma Pharmaceuticals PLC engages in the development, manufacture, and marketing of generic and in-licensed pharmaceutical products in solid, semi-solid, liquid, and injectable final dosage forms. The company operates primarily in the United States, Europe, the Middle East, and North Africa. Segments The company operates in three segments: Branded Pharmaceuticals, Generic Pharmaceuticals, and Injectable Pharmaceuticals. Branded The Branded Pharmaceuticals segment develops, manufactures, and markets 241 solid, semi-solid, and liquid branded pharmaceutical products in 460 dosage strengths and forms, including 33 patented products under-license from the originator. Generics The Generic Pharmaceuticals segment develops, manufactures, and markets 47 non-branded generic pharmaceutical products in 105 dosage strengths and forms. Injectables The Injectable Pharmaceuticals segment develops, manufactures, and markets 81 injectable products in 202 dosage strengths and forms with a focus on anti-infectives, oncology, central nervous system, and cardiology areas. History Hikma Pharmaceuticals PLC was founded in 1978.

 

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup
Recently Viewed
HIK:LN 2,277.00 GBp +34.00

HIK Competitors

Market data is delayed at least 15 minutes.

Company Last Change
Akorn Inc $41.21 USD +2.20
Impax Laboratories Inc $43.97 USD +0.54
Pfizer Ltd/India 2,287 INR +81.25
Sagent Pharmaceuticals Inc $19.87 USD +0.34
Medicines Co/The $31.75 USD +1.35
View Industry Companies
 

Industry Analysis

HIK

Industry Average

Valuation HIK Industry Range
Price/Earnings 28.5x
Price/Sales 4.7x
Price/Book 5.5x
Price/Cash Flow 28.4x
TEV/Sales 4.7x
 | 

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact HIKMA PHARMACEUTICALS PLC, please visit www.hikma.com. Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.